Bonefos clodronate regulatory update

FDA accepted for filing an NDA from SCH's subsidiary Berlex Laboratories (Montville, N.J.) for Bonefos clodronate as an adjuvant oral treatment for reducing the occurrence of bone metastases in stage ...